Modular Medical, Inc. is a development stage company, which engages in the provision of insulin pump technology. The company is headquartered in San Diego, California and currently employs 54 full-time employees. The company went IPO on 2006-01-13. The firm is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The firm's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include two parts - one reusable, one disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; disposable portion removable at any time from an adhesive-backed retainer, which remains in place, and no external controller required, no charging and no battery replacement. MODD1 comes with a variety of methods for the patient to wear the pump. Options include a baseplate with adhesive for attaching to the body that has features for holding the pump to the patient, and overwraps to hold the product to the patient.
Follow-Up Questions
Modular Medical Inc의 CEO는 누구입니까?
Mr. James Besser은 2017부터 회사에 합류한 Modular Medical Inc의 Chief Executive Officer입니다.
MODD 주식의 가격 성능은 어떻습니까?
MODD의 현재 가격은 $0.6124이며, 전 거래일에 increased 0.77% 하였습니다.
Modular Medical Inc의 주요 사업 주제나 업종은 무엇입니까?
Modular Medical Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Modular Medical Inc의 시가총액은 얼마입니까?
Modular Medical Inc의 현재 시가총액은 $33.8M입니다
Modular Medical Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Modular Medical Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다